Zynat Jazyra, Guo Yuyu, Lu Yingli, Lin Dongping
Department of Endocrinology and Metabolism, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Int J Endocrinol. 2016;2016:5308347. doi: 10.1155/2016/5308347. Epub 2016 Aug 25.
Objectives. This study aimed to explore the expression of GLP-1 receptor in hypothalamus and gastrointestinal tissues after Roux-en-Y gastric bypass (RYGB) surgery in diabetic rats. Methods. Male 12-week-old Wistar rats (control) and Goto-Kakizaki rats (diabetic) were randomly divided into two groups, respectively: control sham surgery group (C), control RYGB group (C + R), diabetic sham surgery group (D), and diabetic RYGB group (D + R). Body weight and blood glucose were monitored before and after surgery every week. Eight weeks after surgery, all rats were sacrificed and the serum fasting GLP-1 concentrations were measured by ELISA. GLP-1R and DPP-4 expression in hypothalamus and ileum were measured by RT-PCR. Results. The body weight and fasting/random blood glucose in the D + R group decreased significantly compared with the D group (P < 0.05). Serum GLP-1 levels in diabetic rats treated with RYGB were higher than the corresponding sham surgery rats. The expression of GLP-1R of hypothalamus in RYGB-treated diabetic rats was significantly higher than those of the sham surgery diabetic rats and both control group rats (P < 0.05). We found a negative correlation between hypothalamus GLP-1R mRNA and blood glucose level. No significant difference was seen in ileum GLP-1R and DPP-4 expression among all groups. Conclusions. RYGB efficiently promoted serum GLP-1 levels and the expression of GLP-1 receptor in the hypothalamus in diabetic rats. These data suggest that the hypothalamus GLP-1R may play an important role in the GLP-1 system for improving glucose homeostasis after reconstruction of the gastrointestinal tract.
目的。本研究旨在探讨糖尿病大鼠行Roux-en-Y胃旁路术(RYGB)后下丘脑和胃肠道组织中胰高血糖素样肽-1(GLP-1)受体的表达。方法。将12周龄雄性Wistar大鼠(对照组)和Goto-Kakizaki大鼠(糖尿病组)分别随机分为两组:对照组假手术组(C)、对照组RYGB组(C + R)、糖尿病组假手术组(D)和糖尿病组RYGB组(D + R)。每周监测手术前后的体重和血糖。术后8周,处死所有大鼠,采用酶联免疫吸附测定法(ELISA)测定血清空腹GLP-1浓度。采用逆转录-聚合酶链反应(RT-PCR)检测下丘脑和回肠中GLP-1R和二肽基肽酶-4(DPP-4)的表达。结果。与D组相比,D + R组的体重和空腹/随机血糖显著降低(P < 0.05)。接受RYGB治疗的糖尿病大鼠血清GLP-1水平高于相应的假手术大鼠。接受RYGB治疗的糖尿病大鼠下丘脑GLP-1R的表达显著高于假手术糖尿病大鼠和两组对照组大鼠(P < 0.05)。我们发现下丘脑GLP-1R mRNA与血糖水平呈负相关。各组回肠GLP-1R和DPP-4表达未见显著差异。结论。RYGB有效提高了糖尿病大鼠血清GLP-1水平及下丘脑GLP-1受体的表达。这些数据表明,下丘脑GLP-1R可能在胃肠道重建后改善葡萄糖稳态的GLP-1系统中发挥重要作用。